NPM1A in Plasma is a Potential Prognostic Biomarker in Acute Myeloid Leukemia

OBJECTIVE: The aim of the study was to investigate whether nucleophosmin type A mutation (NPM1A) in plasma was associated with the prognosis of patients with acute myeloid leukemia (AML). METHODS: Plasma NPM1A levels were investigated in 80 AML patients, 22 patients with benign hematopathy and 12 he...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Open Life Sci
Glavni autori: Sun, Chengming, Gao, Yujie, Yang, Liping, Shao, Huiyuan, li, Jie, Gao, Xuejun, Ma, Li, Lin, Mingming, Sui, Jingrui
Format: Artigo
Jezik:Inglês
Izdano: De Gruyter 2018
Teme:
Topical Issue on Precision Medicine
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7874735/
https://ncbi.nlm.nih.gov/pubmed/33817088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/biol-2018-0028
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items